Tag: pharmacovigilance
-
Valproate in pregnancy falls to new low as safety measures take effect
The latest data on valproate in pregnancy A new update from the NHS Medicines and Pregnancy Dashboard, published on 25 September 2025, shows a continued drop in the use of sodium valproate by women of childbearing age and a very small number of pregnancies affected by the drug. Between October 2024 and March 2025, five…
-
Record-low NHS data show valproate prescriptions in pregnancy as more women stop before pregnancy
Key findings from the NHS Medicines and Pregnancy Dashboard New data released by NHS England reveal a continued decline in the number of women prescribed sodium valproate during pregnancy. Between October 2024 and March 2025, five women were prescribed valproate while pregnant, and notably, none of these women started the medication during pregnancy. In the…
-
Valproate in pregnancy at record low as NHS data show continued decline
Valproate in pregnancy dips to a record low, NHS data suggest The latest NHS Medicines and Pregnancy Dashboard, published on 25 September 2025, reveals a continued fall in the use of sodium valproate among women who are pregnant. In the six-month window from October 2024 to March 2025, only five women were prescribed valproate during…